New Study: Lowering Dietary Sodium Lowers Blood Pressure

AdobeStock Lic. 331001454
AdobeStock Lic. 331001454 

A recent study published in JAMA on November 11, 2023, presents groundbreaking findings regarding the impact of dietary sodium intake on blood pressure, particularly in middle-aged to elderly individuals. A decline in blood pressure (BP) going from a high- to a low-sodium diet was confirmed regardless of hypertension status and antihypertensive medications used, a crossover trial found.

This research is significant in the context of ongoing debates around dietary sodium recommendations and their variability in blood pressure response, especially among those on antihypertensive medications.

"For most middle-aged to elderly adults, dietary sodium reduction resulted in clinically meaningful BP lowering which was safely achieved within 1 week. The effect of dietary sodium reduction in BP is comparable to a commonly utilized first-line antihypertensive medication [such as] hydrochlorothiazide 12.5 mg daily," reported Deepak Gupta, MD, MSCI, of Vanderbilt University Medical Center in Nashville.

"We need to make it simple for participants to be successful with their diet," Gupta said during an AHA press conference. He cited structural barriers to lowering dietary sodium, which is added in high levels during industrial and commercial food preparation. One estimate puts roughly 70% of dietary sodium as coming from packaged, processed, and restaurant foods.

The FDA currently estimates that Americans eat on average about 3,400 mg of sodium per day. A couple of years ago, the FDA advised voluntary sodium reduction goals with the purpose of reducing average sodium intake in the U.S. to 3,000 mg/day, or 12% over 2.5 years.

The 2020-2025 Dietary Guidelines for Americans had gone further to recommend a limit of 2,300 mg of sodium daily for everyone 14 years and older.

Dr. Gupta continued, "Now, they didn't have kidney disease, they were not obese, they didn't have heart disease," acknowledged Bakris, who was not involved with the present study. Still, he maintained: "Do not underestimate the power of salt."

Study Design and Objectives

The study involved a prospectively allocated diet order with crossover among 213 participants aged 50 to 75 years, enrolled between April 2021 and February 2023 in two U.S. cities. It included individuals with varying blood pressure statuses: normotension (25%), controlled hypertension (20%), uncontrolled hypertension (31%), and untreated hypertension (25%)​​. The participants underwent two dietary interventions:

What Were The Key Findings?

What Are The Implications of the Study?

Compared with the high-sodium diet, the low-sodium diet induced a drop in mean arterial pressure in 73.4% of individuals.  Sodium reduction significantly lowered BP in the majority of middle-aged to elderly adults in this study. The decline in BP from a high-sodium diet to a low-sodium diet was independent of hypertension status and antihypertensive medication use, generally consistent across subgroups, and did not result in excess adverse events. In fact, adverse events were mild and similarly likely during the high- (9.9%) and low-sodium diet phases (8.0%). These were most commonly headaches, gastrointestinal side effects, and edema with the high-sodium diet, and cramping and weakness with the low-sodium diet.

The study's findings provide robust evidence supporting the reduction of dietary sodium as a crucial factor in managing blood pressure, a key risk factor for cardiovascular diseases. The significance of these results lies in their universality across different groups, regardless of hypertension status or medication use. This research reinforces the importance of dietary interventions in the management of blood pressure and highlights the potential of a low-sodium diet as an effective, non-pharmacological approach to controlling hypertension and reducing cardiovascular risk.



Dr. Mark L. Meyer Dr. Meyer graduated from Haverford College with a Bachelor of Science, High Honors, in cellular and molecular biology, Phi Beta Kappa, Magna Cum Laude. He attended the Yale University School of Medicine, where he also completed a categorical residency in Internal Medicine, served for one year as an Emergency Department attending physician, and held the title of Clinical Instructor in the Department of Surgery. During this time, Dr. Meyer obtained a J.D. from the Yale Law School, concentrating on medical ethics, scientific research law, and FDA law. He then completed a fellowship in Cardiovascular Diseases at the Hospital of the University of Pennsylvania, where he obtained Level 3 Nuclear Cardiology training.

You Might Also Enjoy...

Adobe Stock Lic. # 530131342

Women's Heart Risks Increase After Menopause

A groundbreaking study led by Ella Ishaaya, MD, an internal medicine physician at Harbor-UCLA Medical Center in Torrance, California, sheds light on the specific challenges post-menopausal women face regarding cardiovascular health,.